LUMETTI, Federica
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.416
EU - Europa 2.061
AS - Asia 1.029
SA - Sud America 38
AF - Africa 9
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 5
Totale 7.566
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.381
IT - Italia 635
GB - Regno Unito 522
SG - Singapore 303
SE - Svezia 272
CN - Cina 261
DE - Germania 192
HK - Hong Kong 135
FI - Finlandia 104
TR - Turchia 97
ID - Indonesia 84
FR - Francia 73
UA - Ucraina 69
BG - Bulgaria 50
IN - India 46
CA - Canada 29
BR - Brasile 28
ES - Italia 23
IE - Irlanda 22
MY - Malesia 17
BE - Belgio 16
IR - Iran 16
NL - Olanda 16
VN - Vietnam 16
RU - Federazione Russa 15
JP - Giappone 13
CZ - Repubblica Ceca 10
KR - Corea 9
LT - Lituania 9
RO - Romania 8
TW - Taiwan 8
AU - Australia 6
CL - Cile 6
IL - Israele 5
PL - Polonia 5
ZA - Sudafrica 5
BZ - Belize 4
EU - Europa 4
IQ - Iraq 4
PK - Pakistan 4
CH - Svizzera 3
GR - Grecia 3
HU - Ungheria 3
RS - Serbia 3
BY - Bielorussia 2
MX - Messico 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PE - Perù 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
CO - Colombia 1
EC - Ecuador 1
EG - Egitto 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LU - Lussemburgo 1
MA - Marocco 1
NG - Nigeria 1
NP - Nepal 1
PS - Palestinian Territory 1
PT - Portogallo 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
Totale 7.566
Salva come PNG Salva come JPEG
Città #
Santa Clara 922
Fairfield 445
Southend 415
Chandler 414
Woodbridge 251
Ashburn 250
Singapore 226
Nyköping 190
Ann Arbor 180
Houston 175
Seattle 154
Wilmington 151
Jacksonville 150
Cambridge 135
Hong Kong 134
Dearborn 109
San Diego 87
Helsinki 84
Jakarta 83
Modena 80
Princeton 56
Bologna 54
Izmir 53
Sofia 50
Beijing 47
New York 47
Milan 41
Bremen 39
Parma 39
Atlanta 32
Shanghai 31
London 26
Eugene 25
Frankfurt am Main 22
Valencia 20
Redwood City 19
Brussels 15
Ottawa 15
New Delhi 14
Dublin 13
Rome 13
Boardman 12
Florence 12
Los Angeles 11
San Jose 11
Antalya 10
Dong Ket 10
Munich 10
Reggio Emilia 10
Toronto 10
Brno 9
Chicago 9
Guangzhou 9
Napoli 9
Turin 9
Brescia 7
Grafing 7
Mumbai 7
Padova 7
Paris 7
Pune 7
Amsterdam 6
Chengdu 6
Dallas 6
Hefei 6
Kunming 6
Moscow 6
Nanjing 6
Naples 6
Tehran 6
Tokyo 6
Van 6
Castenaso 5
Grosseto 5
Norwalk 5
Saint Louis 5
San Mateo 5
Artena 4
Belize City 4
Cadelbosco 4
Castelfranco Emilia 4
Cesena 4
Des Moines 4
Falls Church 4
Johannesburg 4
Kilburn 4
Palermo 4
Portacomaro 4
São Paulo 4
Taichung 4
Treviso 4
West Hollywood 4
Ballybofey 3
Bari 3
Boston 3
Caserta 3
Castelfranco di Sotto 3
Castelnuovo Rangone 3
Firenzuola 3
Frattamaggiore 3
Totale 5.664
Salva come PNG Salva come JPEG
Nome #
Systemic sclerosis progression INvestiGation (SPRING) Italian registry: Demographic and clinico-serological features of the scleroderma spectrum 265
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline 236
Cryoglobulinemic vasculitis and skin ulcers. Our therapeutic strategy and review of the literature 236
Established coronary artery disease in systemic sclerosis compared to type 2 diabetic female patients: a cross-sectional study 233
Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature 223
Cardio-pulmonary disease management in patients with systemic sclerosis: cardio-rheumatology clinic and patient care standardisation proposal 206
Rituximab in the treatment of patients with systemic sclerosis. Our experience and review of the literature 205
Cardiac involvement in systemic sclerosis: identification of high-risk patient profiles in different patterns of clinical presentation 201
Breast cancer in systemic sclerosis: Results of a cross-linkage of an Italian Rheumatologic Center and a population-based Cancer Registry and review of the literature. 195
Management of cardiopulmonary disease in patients with systemic sclerosis: cardiorheumatology clinic and patient care standardization proposal 173
Diagnosis and treatment of rheumatoid arthritis in the Emilia Romagna region: a prospective population-based study 168
Beyond cat scratch disease: a case report of bartonella infection mimicking vasculitic disorder 166
Scleroderma Digital Ulcers Complicated by Infection with Fecal Pathogens. 164
APPLICATION OF CRITERIA FOR THE DIAGNOSIS OF “CLINICAL OSTEOPOROSIS ” IN A POPULATION OF POSTMENOPAUSAL WOMEN FROM EMILIA-ROMAGNA REGION 161
Use of Neem oil and Hypericum perforatum for treatment of calcinosis-related skin ulcers in systemic sclerosis 160
Osteomyelitis complicating scleroderma digital ulcers. 158
COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study 142
Long-term treatment with rituximab in interstitial lung disease related to systemic sclerosis: our clinical experience 140
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 140
COMPLEMENT DEPLETION IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TOCILIZUMAB: A MARKER OF CLINICAL EFFICACY? 136
Autologous Fat Grafting for the Oral and Digital Complications of Systemic Sclerosis: Results of a Prospective Study 135
Advanced oxidation protein products in serum of patients with systemic sclerosis: a possible indicator of clinical evolution 131
DIGITAL NECROSIS IN SYSTEMIC SCLEROSIS NOT ONLY A MICROVASCULAR DISEASE: A CASE REPORT 129
Predictive Value of DLCO Reduction in Scleroderma Patients Without Cardio-Pulmonary Involvement at Baseline 127
RETENTION RATE OF ADALIMUMAB AND ABP 501 IN THE TREATMENT OF A LARGE COHORT OF PATIENTS WITH INFLAMMATORY ARTHRITIS: A REAL LIFE RETROSPECTIVE ANALYSIS 127
Scleroderma skin ulcers definition, classification and treatment strategies our experience and review of the literature 127
SEVERE VITAMIN D DEFICIENCY IN SYSTEMIC SCLEROSIS 126
Photobiomodulation Therapy: A New Light in the Treatment of Systemic Sclerosis Skin Ulcers 122
A SELF-ADMINISTERED QUESTIONNAIRE MAY ALLOW GENERAL PRACTITIONERS TO PERFORM A RAPID SCREENING TO IDENTIFY PATIENTS AT RISK FOR FRAGILITY FRACTURES AND TO ADDRESS THEM TO BONE METABOLISM SPECIALIZED CLINICAL CENTERS 121
Treatment with Rituximab in Systemic Sclerosis Patients: Our Experience in a Pilot Clinical Trial 121
Long-term treatment of scleroderma-related digital ulcers with iloprost: a cohort study 118
Adalimumab and ABP 501 in the Treatment of a Large Cohort of Patients with Inflammatory Arthritis: A Real Life Retrospective Analysis 112
PSYCHIATRIC DISORDERS IN RHEUMATOLOGY: EVALUATION OF A SCREENING PROTOCOL IN 100 HOSPITALIZED PATIENTS 109
Iloprost use and medical management of systemic sclerosis-related vasculopathy in Italian tertiary referral centers: results from the PROSIT study 101
Invited Response on: Comments on "Autologous Fat Grafting for the Oral and Digital Complications of Systemic Sclerosis: Results of a Prospective Study" 100
Predictors of DAPSA Response in Psoriatic Arthritis Patients Treated with Apremilast in a Retrospective Observational Multi-Centric Study (2023-02-07) 98
KIENBOCK DISEASE IN A PATIENT WITH SSc: A CASE REPORT 96
Efficacy and Drug Survival after Switching from Etanercept to the Biosimilar SB4: A Real-Life Long-Term Study 95
AB0724 Cardio-pulmonary disease management in patients with systemic sclerosis: cardio-rheumatology clinic and patient care standardisation proposal 94
AB0760 Advanced oxidation protein products in serum of patients with systemic sclerosis: a possible indicator of clinical evolution 91
AB0212 LONG-TERM TREATMENT WITH RITUXIMAB IN SYSTEMIC SCLEROSISMANAGEMENT: AN OVERVIEW OF THE CLINICAL EXPERIENCE FROM A REAL-LIFE SETTING 91
AB0645 CANNABINOIDS IN THE TREATMENT OF PAIN RELATED TO SYSTEMIC SCLEROSIS SKIN ULCERS: OUR EXPERIENCE 90
From Localized Scleroderma to Systemic Sclerosis: Coexistence or Possible Evolution 89
AB0611 STRAIN ANALYSIS OF THE RIGHT VENTRICLE USING 2D-SPECKLE TRACKING ECHOCARDIOGRAPHY IN A COHORT OF PATIENTS WITH SYSTEMIC SCLEROSIS 88
Thu0349 autologous fat grafting in the treatment of patients with systemic sclerosis: current experience and future prospects 84
Overall mortality in combined pulmonary fibrosis and emphysema related to systemic sclerosis 83
Sex-related Differences in Systemic Sclerosis: A Multicenter Cross-sectional Study From the National Registry of the Italian Society for Rheumatology 83
SAT0285 EVALUATION OF CHRONIC PAIN IN PATIENTS WITH SYSTEMIC SCLEROSIS COMPARED TO THOSE WITH CHRONIC HEADACHE AND RHEUMATOID ARTHRITIS 78
Erratum to "From Localized Scleroderma to Systemic Sclerosis: Coexistence or Possible Evolution" 77
THU0600 a case of systemic sclerosis complicated by renal crisis: potential etiopathogenetic role of cytomegalovirus and treatment 77
FRI0442 Long-term treatment with rituximab in interstitial lung disease related to systemic sclerosis: our clinical experience 71
One-year clinical experience on the use of Nintedanib in Systemic Sclerosis 64
Infections of scleroderma digital ulcers: A single center cohort retrospective study 64
Promising use of filgotinib in patients affected by systemic sclerosis: Preliminary data from a case series of 5 patients 59
Baseline Ultrasound Assessment Improves the Response to Apremilast in Patients with Psoriatic Arthritis: Results from a Multicentre Study 53
FRI0651 Quantitative chest ct predicts 8-years-mortality and comorbidity in systemic sclerosis 51
OP0063 QUANTITATIVE COMPUTED TOMOGRAPHY PREDICTS 10-YEAR MORTALITY IN INTERSTITIAL LUNG DISEASE RELATED TO SYSTEMIC SCLEROSI 46
Assessing hand grasp in patients with systemic sclerosis using the 16-grasp test: Preliminary results from a multidisciplinary study group 38
Altered pathways of keratinization, extracellular matrix generation, angiogenesis, and stromal stem cells proliferation in patients with systemic sclerosis 32
EFFICACY OF CERTOLIZUMAB PEGOL FOR DISEASE CONTROL OF PATIENTS AFFECTED BY ENTEROPATHIC SPONDYLARTHRITIS FOLLOWED BY THE JOINT GASTRO-RHEUMATOLOGICAL CLINIC 32
ACCERTAMENTO DELLA DISABILITÀ NELLE MALATTIE REUMATOLOGICHE (EX L.R. N.4 DEL 19 FEBBRAIO 2008) PROPOSTA DI PROTOCOLLO ORGANIZZATIVO 28
Real life use of prostacyclin analog (Iloprost), a multi-centric survey data from the scleroderma study group Emilia Romagna (Sclero-RER) and review of the literature 27
Long-Term Retention Rate of Tofacitinib in Rheumatoid Arthritis: An Italian Multicenter Retrospective Cohort Study 26
Molecular Pathways of Breast Cancer in Systemic Sclerosis: Exploratory Immunohistochemical Analysis from the Sclero-Breast Study 26
PROBABILITÀ DI SIEROCONVERSIONE DEL TEST QUANTIFERON DURANTE LA TERAPIA BIOTECNOLOGICA: DATI PRELIMINARI DI UNO STUDIO RETROSPETTIVO CONDOTTO PRESSO L’ARTHRITIS CLINIC DELL’AZIENDA OSPEDALIERO-UNIVERSITARIA POLICLINICO DI MODENA 25
CONFRONTO TRA STRATEGIE DI TERAPIA AVANZATA DI 2° E 3° LINEA NELLA ARTRITE PSORIASICA: RISULTATI PRELIMINARI DALLO STUDIO OSSERVAZIONE RETROSPETTIVO BIRRA 25
L’IPERTENSIONE POLMONARE: DALLE NUOVE LINEE GUIDA ALLA PRATICA CLINICA 25
Influence of safety warnings on the prescribing attitude of JAK 2inhibitors for rheumatoid arthritis in Italy 25
CYCLING VS SWAP TNFi AND IL17i IN PSORIATIC ARTHRITIS: RESULTS FROM THE BIRRA RETROSPECTIVE OBSERVATIONAL STUDY 24
Cycling versus swapping strategieswith TNF-α inhibitors and IL-17 inhibitors in psoriatic arthritis in clinical practice 24
Therapeutic Effects of Apremilast on Enthesitis and Dactylitis in Real Clinical Setting: An Italian Multicenter Study 21
The predictive role of the TAPSE/sPAP ratio for cardiovascular events and mortality in systemic sclerosis with pulmonary hypertension 20
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase 19
DIFFERENCES BETWEEN SELECTIVE AND UNSELECTIVE JAKi: RESULTS FROM A MULTICENTRIC, REAL LIFE STUDY CARRIED OUT ON PATIENTS WITH RA 18
POS0604 JAKi’S SURVIVAL RATE AND PREDICTORS OF DISCONTINUATION IN A COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS 15
Multicenter observational study on the efficacy of selective Janus Kinase-1 inhibitor upatacitinib in rheumatoid arthritis 14
Effectiveness and Predictors of Long-Term Treatment Response to Tofacitinib in Rheumatoid Arthritis Cohort: General Analysis and Focus on High-Cardiovascular-Risk Subgroup— AMulticenter Study 8
Totale 7.708
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.890
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.890
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020626 0 0 0 0 0 151 157 124 95 25 46 28
2020/20211.008 66 21 50 72 107 97 142 138 53 110 109 43
2021/20221.160 31 45 86 100 47 88 42 91 150 95 243 142
2022/20231.261 157 147 89 114 127 160 51 119 177 19 51 50
2023/2024970 27 61 47 143 196 55 84 98 23 33 74 129
2024/20251.678 121 52 64 233 740 468 0 0 0 0 0 0
Totale 7.708